Multiple Sclerosis Clinical Trials

A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 722 clinical trials
Featured trial
Multiple Sclerosis

LIVING WITH MULTIPLE SCLEROSIS?The purpose of this study is to find out the effect of the study drug, on the body in patients with MS by assessing your

spasticity
  • 0 views
  • 28 Oct, 2021
  • 1 location
Featured trial
A research study for patients who have been diagnosed with multiple sclerosis

A research study for patients who have been diagnosed with multiple sclerosis

  • 332 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A research study for patients who have been diagnosed with multiple sclerosis

A research study for patients who have been diagnosed with multiple sclerosis

dimethyl fumarate
  • 719 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes in patients with relapsing multiple sclerosis transitioning from dimethyl fumarate or fingolimod therapy

This study will look to see if ofatumumab works and is safe in adults with relapsing multiple sclerosis (MS) who are switching from their current oral medicines (dimethyl fumarate or fingolimod

fingolimod
multiple sclerosis
relapsing multiple sclerosis
disease or disorder
dimethyl fumarate
  • 0 views
  • 17 May, 2021
  • 1 location
Featured trial
A PHASE IIIB MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY AND PHARMACOKINETICS OF A HIGHER DOSE OF OCRELIZUMAB IN ADULTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

The purpose of this study is to compare the effects, good or bad, of a higher dose of ocrelizumab versus the approved dose of ocrelizumab on participants with PPMS. In this study, you will get either the approved dose or a higher dose of ocrelizumab. 

multiple sclerosis
ocrelizumab
  • 0 views
  • 17 May, 2021
  • 1 location
Featured trial
Multiple Sclerosis - (MS) Primary Progressive Multiple Sclerosis

Multiple Sclerosis - (MS) Primary Progressive Multiple Sclerosis

  • 334 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A study of rHIgM22 dosage in relapsing MS patients.

A study of rHIgM22 dosage in relapsing MS patients.

  • 184 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.

Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.

  • 358 views
  • 08 Nov, 2020
  • 1 location
Featured trial
An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing Arbaclofen Placarbil Safety in Subjects With Spasticity Associated With Multiple Sclerosis

An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing

  • 162 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Placebo-controlled Randomized Withdrawal Evaluation of the Efficacy and Safety of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis

A Placebo-controlled Randomized Withdrawal Evaluation of the Efficacy and Safety of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis

  • 134 views
  • 08 Nov, 2020
  • 1 location